Review: Implantable cardioverter defibrillator therapy and the need for concomitant antiarrhythmic drugs

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 12, Issue 3, 2007, Pages 175-180

  Singh, Steven ^a   Murawski, Matthew M ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

Antiarrhythmic drugs; Implantable cardioverter defibrillator; Quality of life

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; AZIMILIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARVEDILOL; DISOPYRAMIDE; DOFETILIDE; FLECAINIDE; LIDOCAINE; METOPROLOL; MEXILETINE; MORACIZINE; PROCAINAMIDE; PROPAFENONE; PROPRANOLOL; QUINIDINE; SOTALOL; VERAPAMIL;

ADRENERGIC STIMULATION; ANXIETY; CARDIAC PATIENT; CLINICAL TRIAL; DEFIBRILLATOR; HEART ARRHYTHMIA; HEART FAILURE; HEART PACING; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPOTENSION; IMPLANT; INCIDENCE; PRIORITY JOURNAL; QUALITY OF LIFE; RECOMMENDED DRUG DOSE; REVIEW; SHOCK; TACHYCARDIA; CARDIOVERSION; HEART VENTRICLE FIBRILLATION; MULTIMODALITY CANCER THERAPY; SUDDEN DEATH;

ANTI-ARRHYTHMIA AGENTS; ANXIETY; COMBINED MODALITY THERAPY; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; HUMANS; QUALITY OF LIFE; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION;

EID: 34548188999     PISSN: 10742484     EISSN: None     Source Type: Journal    
DOI: 10.1177/1074248407305608     Document Type: Review

References (50)

1. Myerburg RJ, Kessler KM, Estes D., et al. Long-term survival after prehospital cardiac arrest: analysis of outcome during an 8-year study. Circulation. 1984 ; 70: 538-546.
2. Eisenberg MS, Hallstrom A., Bergner L. Long-term survival after out-of-hospital cardiac arrest. N Engl J Med. 1982 ; 306: 1340-1343.
3. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 1997 ; 337: 1576-1583.
4. Connolly SJ, Gent M., Roberts RS, et al. Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation. 2000 ; 101: 1297-1302.
5. Kuck KH, Cappato R., Siebels J., Ruppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation. 2000 ; 102: 748-754.
6. Connolly SJ, Hallstrom AP, Cappato R., et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials: AVID, CASH and CIDS studies: antiarrhythmics vs. implantable defibrillator study: Cardiac arrest study Hamburg: Canadian Implantable Defibrillator Study. Eur Heart J. 2000 ; 21: 2071-2078.
7. Kadish A., Dyer A., Daubert JP, et al. Prophylactic defibrillator implantations in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004 ; 350: 2151-2158.
8. Dorian P., Philippon F., Thibault B., et al. Randomized controlled study of detection enhancements versus rate-only detection to prevent inappropriate therapy in a dual-chamber implantable cardioverter-defibrillator. Heart Rhythm. 2004 ; 1: 540-547.
9. Nanthakumar K., Paquette M., Newman D., Deno D., Malden L., Gunderson B. Inappropriate therapy from atrial fibrillation and sinus tachycardia in automated implantable cardioverter defibrillators. Am Heart J. 2000 ; 139: 797-803.
10. Rosenqvist M., Beyer T., Block M., den Dulk K., Minten J., Lindemans F. Adverse events with transvenous implantable cardioverter-defibrillators: a prospective multicenter study. Circulation. 1998 ; 98: 663-670.
11. Greene HL The implantable cardioverter-defibrillator. Clin Cardiol. 2000 ; 23: 315-326.
12. Dorian P., Borggrefe M., Al-Khalidi HR, et al. Shock Inhibition Evaluation with azimilide (SHIELD) Investigators: placebo-controlled randomized clinical trial of azimilide for prevention of ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator. Circulation. 2004 ; 110: 3646-3654.
13. Wathen MS, Sweeney MO, DeGroot PJ, et al. PainFREE Investigators: shock reduction using anti-tachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease. Circulation. 2001 ; 104: 796-801.
14. Pelletier D., Gallagh R., Mitten-Lewis S., McKinley S., Squire J. Australian implantable cardiac defibrillator recipients: quality of life issues. Int J Nurs Pract. 2002 ; 8: 68-74.
15. Ahmad M., Bloomstein AM, Roelke L., Bernstein M., Parsonnet V. Patients' attitudes toward implanted defibrillator shocks. Pacing Clin Electrophysiol. 2000 ; 23: 934-938.
16. Kamphuis Hcm, de Leeuw Jrj, Derksen R., Hauer R., Winnubst Jam. A 12-month quality of life assessment of cardiac arrest survivors treated with and without an implantable cardioverter defibrillator. Europace. 2002 ; 4: 417-425.
17. Irvine J., Dorian P., Baker B., et al. Quality of life in the Canadian Implantable Defibrillator Study (CIDS). Am Heart J. 2002 ; 144: 282-289.
18. McCready MJ, Exner DV Quality of life and psychological impact of implantable cardioverter defibrillators: focus on randomized controlled trial data. Cardiac Electrophysiol Rev. 2003 ; 7: 63-70.
19. Sears SE Jr, Conti JB Understanding implantable cardioverter defibrillator shocks and storms: medical and psychosocial considerations for research and clinical care. Clin Cardiol. 2003 ; 26: 107-111.
20. Reid SS, McKinley S., Nagy S. Outcomes, problems and quality of life with the implantable cardioverter defibrillator. Aust J Adv Nurs. 1999 ; 1614-19.
21. Herbst JH, Goodman M., Feldstein S., Reilly JM Health-related quality-of-life assessment of patients with life-threatening ventricular arrhythmias. Pacing Clin Electrophysiol. 1999 ; 22 (6, pt1). 915-926.
22. Groh WJ, Bhakta D., Lowe MR, Bennett SJ Come see the softer side of clinical outcomes: quality of life measures in implanted defibrillator trials. J Cardiovasc Electrophysiol. 2004 ; 15: 292-294.
23. Kolata G. Extending life, defibrillators can prolong misery. New York Times. March 25, 2002: 1.
24. Kamphuis Hcm, de Leeuw Jrj, Derksen R., Hauer Rnw, Winnubst Jam. Implantable cardioverter defibrillator recipients: quality of life in recipients with and without ICD shock delivery: a prospective study. Europace. 2003 ; 5: 381-389.
25. Heller SS, Ormont MA, Lidagoster L., Sciacca RR, Steinberg S. Psychosocial outcome after ICD implantation: a current perspective. Pacing Clin Electrophysiol. 1998 ; 21: 1207-1215.
26. Chevalier P., Verrier P., Kirkorian G., Touboul P., Cottraux J. Improved appraisal of the quality of life in patients with automatic implantable cardioverter defibrillator: a psychometric study. Psychother Psychosom. 1996 ; 65: 49-56.
27. Hegel MT, Griegel LE, Black C., Goulden L., Ozahowski T. Anxiety and depression in patients receiving implanted cardioverter-defibrillators: a longitudinal investigation. Int J Psychiatry Med. 1997 ; 27: 57-69.
28. Sears SF Jr, Todaro JF, Lewis TS, Sotile W., Conti JB Examining the psychosocial impact of implantable cardioverter defibrillators: a literature review. Clin Cardiol. 1999 ; 22: 481-489.
29. Schulman JK, Muskin PR, Shapiro PA Psychiatry and cardiovascular disease. Focus. 2005 ; 3: 208-224.
30. Sirois BC, Burg MM Negative emotion and coronary heart disease: a review. Behav Mod. 2003 ; 27: 83-102.
31. Lane D., Carroll D., Lip GY Anxiety, depression, and prognosis after myocardial infarction: is there a causal association? J Am Coll Cardiol. 2003 ; 42: 1808-1810.
32. Jiang W., Kuchibhatla M., Cuffe MS, et al. Prognostic value of anxiety and depression in patients with chronic heart failure. Circulation. 2004 ; 110: 3452-3456.
33. Van Ittersum M., de Greef M., van Gelder I., et al. Fear of exercise and health-related quality of life in patients with an implantable cardioverter defibrillator. Int J Rehabil Res. 2003 ; 26: 117-122.
34. Godemann F., Butter C., Lampe F., Linden M., Werner S., Behrens S. Determinants of the quality of life (QOL) in patients with an implantable cardioverter/defibrillator (ICD). Quality Life Res. 2004 ; 13: 411-416.
35. Fetzer SJ The patient with an implantable cardioverter defibrillator. J Perianesth Nurs. 2003 ; 18: 398-413.
36. Thomas SA, Friedmann E., Kelley FJ Living with an implantable cardioverter-defibrillator: a review of the current literature related to psychosocial factors. AACN Clin Issues. 2001 ; 12: 156-163.
37. Dougherty CM, Benoliel JQ, Bellin C. Domains of nursing intervention after sudden cardiac arrest and automatic internal cardioverter defibrillator implantation. Heart Lung. 2000 ; 29: 79-86.
38. Carlsson E., Olsson SB, Hertervig E. The role of the nurse in enhancing quality of life in patients with an implantable cardioverter-defibrillator: the Swedish experience. Prog Cardiovasc Nurs. 2002 ; 17: 18-25.
39. Albarran JW, Tagney J., James J. Partners of ICD patients: an exploratory study of their experiences. Eur J Cardiovasc Nurs. 2004 ; 3: 201-210.
40. Sola CL, Bostwick JM Implantable cardioverterdefibrillators, induced anxiety, and quality of life. Mayo Clin Proc. 2005 ; 80: 232-237.
41. Dunbar SB, Kimble LP, Jenkins LS, et al. Association of mood disturbance and arrhythmia events in patients after cardioverter defibrillator implantation. Depress Anxiety. 1999 ; 9: 163-168.
42. Farré J., Asso A., Romero J., et al. Antiarrhythmic drugs in patients with an automatic implantable defibrillator. Pacing Clin Electrophysiol. 1995 ; 18: 579-591.
43. Dorian P. Combination ICD and drug treatments: best options. Resuscitation. 2000 ; 45: S3 - S6.
44. Movsowitz C., Marchlinski FE Interactions between implantable cardioverter-defibrillators and class III agents. Am J Cardiol. 1998 ; 82: 411-481.
45. Exner DV, Reiffel JA, Epstein AE, et al. Beta-blocker use and survival in patients with ventricular fibrillation or symptomatic ventricular tachycardia: the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial. J Am Coll Cardiol. 1999 ; 34: 325-333.
46. Gradaus R., Block M., Brachmann J., et al. German EURID Registry: mortality, morbidity, and complications in 3344 patients with implantable cardioverter defibrillators: results from the German ICD Registry EURID. Pacing Clin Electrophysiol. 2003 ; 26 (7, Pt1). 1511-1518.
47. Connolly SJ, Dorian P., Roberts RS, et al. Comparison of β-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators. JAMA. 2006 ; 295: 165-213.
48. Burns KE, Piliotis E., Garcia BM, Ferguson, KA Amiodarone pulmonary, neuromuscular and ophthalmological toxicity. Can Respir J. 2000 ; 7: 193-197.
49. Anderson JL, Prystowsky EN Sotalol: an important new antiarrhythmic. Am Heart J. 1999 ; 137: 388-409.
50. Hjalmarson A. Prevention of sudden cardiac death with beta-blockers. Clin Cardiol. 1999 ; 22 (suppl 8). 11-15.